US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist
  • 74.440
  • +0.970+1.32%
Trading May 15 14:39 ET
186.92BMarket Cap10.82P/E (TTM)

Merck & Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
-1.56%15.53B
6.74%64.17B
6.79%15.62B
4.35%16.66B
7.16%16.11B
8.89%15.78B
1.40%60.12B
5.78%14.63B
6.70%15.96B
3.03%15.04B
Operating revenue
-1.56%15.53B
6.74%64.17B
6.79%15.62B
4.35%16.66B
7.16%16.11B
8.89%15.78B
1.40%60.12B
5.78%14.63B
6.70%15.96B
3.03%15.04B
Cost of revenue
-3.42%3.42B
-5.79%15.19B
-2.15%3.83B
-4.32%4.08B
-6.93%3.75B
-9.83%3.54B
-7.38%16.13B
0.80%3.91B
8.39%4.26B
-4.55%4.02B
Gross profit
-1.02%12.11B
11.33%48.98B
10.06%11.8B
7.51%12.58B
12.31%12.37B
15.85%12.24B
5.06%43.99B
7.73%10.72B
6.10%11.7B
6.11%11.01B
Operating expense
-4.66%6.17B
-29.93%28.75B
-40.09%7.45B
47.49%8.59B
-61.06%6.24B
-4.15%6.48B
73.95%41.04B
92.37%12.43B
-15.80%5.83B
201.75%16.02B
Selling and administrative expenses
2.78%2.55B
2.97%10.82B
2.14%2.86B
8.42%2.73B
1.37%2.74B
0.16%2.48B
4.60%10.5B
4.35%2.8B
-0.04%2.52B
7.56%2.7B
Research and development costs
-9.29%3.62B
-41.25%17.94B
-52.38%4.58B
77.26%5.86B
-73.73%3.5B
-6.64%3.99B
125.35%30.53B
155.02%9.63B
-24.82%3.31B
376.09%13.32B
Operating profit
3.07%5.94B
584.53%20.22B
353.82%4.35B
-32.15%3.98B
222.27%6.13B
51.34%5.76B
-83.84%2.95B
-149.13%-1.71B
43.01%5.87B
-198.91%-5.01B
Net non-operating interest income expense
11.30%-204M
-9.60%-856M
24.17%-182M
16.80%-203M
-43.45%-241M
-76.92%-230M
2.98%-781M
-71.43%-240M
-19.61%-244M
25.33%-168M
Non-operating interest income
49.32%109M
13.70%415M
108.57%146M
73.97%127M
-36.70%69M
-34.82%73M
132.48%365M
-26.32%70M
82.50%73M
626.67%109M
Non-operating interest expense
3.30%313M
10.91%1.27B
5.81%328M
4.10%330M
11.91%310M
25.21%303M
19.13%1.15B
31.91%310M
29.92%317M
15.42%277M
Other net income (expense)
21.43%170M
301.06%571M
104.30%4M
3,962.50%309M
176.77%119M
638.46%140M
72.51%-284M
-156.02%-93M
97.49%-8M
56.34%-155M
Gain on sale of security
----
-610.00%-213M
-230.65%-205M
45.76%-64M
98.31%-4M
-84.58%60M
98.19%-30M
17.33%-62M
74.73%-118M
35.95%-237M
Special income (charges)
43.90%-69M
48.41%-309M
80.00%-51M
55.56%-56M
47.02%-80M
-83.58%-123M
-77.74%-599M
-420.41%-255M
-34.04%-126M
-6.34%-151M
-Less：Restructuring and merger&acquisition
-43.90%69M
-48.41%309M
-80.00%51M
-55.56%56M
-47.02%80M
83.58%123M
77.74%599M
420.41%255M
34.04%126M
6.34%151M
Other non- operating income (expenses)
17.73%239M
216.81%1.09B
16.07%260M
81.78%429M
-12.88%203M
158.33%203M
-64.06%345M
-22.76%224M
-2.48%236M
48.41%233M
Income before tax
4.11%5.9B
955.37%19.94B
303.81%4.17B
-27.22%4.09B
212.58%6.01B
55.34%5.67B
-88.51%1.89B
-158.24%-2.05B
56.85%5.62B
-218.90%-5.34B
Income tax
-9.41%818M
85.38%2.8B
151.95%426M
6.78%929M
-14.44%545M
9.45%903M
-21.17%1.51B
-265.66%-820M
163.64%870M
18.40%637M
Net income
6.67%5.09B
4,444.56%17.13B
405.38%3.74B
-33.45%3.16B
191.44%5.46B
68.74%4.77B
-97.40%377M
-140.62%-1.23B
46.02%4.75B
-251.23%-5.97B
Net income continuous Operations
6.67%5.09B
4,444.56%17.13B
405.38%3.74B
-33.45%3.16B
191.44%5.46B
68.74%4.77B
-97.40%377M
-140.62%-1.23B
46.02%4.75B
-251.23%-5.97B
Minority interest income
20.00%6M
33.33%16M
1M
-20.00%4M
100.00%6M
25.00%5M
71.43%12M
0
0.00%5M
-40.00%3M
Net income attributable to the parent company
6.66%5.08B
4,589.59%17.12B
405.30%3.74B
-33.47%3.16B
191.30%5.46B
68.81%4.76B
-97.49%365M
-140.64%-1.23B
46.09%4.75B
-251.50%-5.98B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
6.66%5.08B
4,589.59%17.12B
405.30%3.74B
-33.47%3.16B
191.30%5.46B
68.81%4.76B
-97.49%365M
-140.64%-1.23B
46.09%4.75B
-251.50%-5.98B
Basic earnings per share
6.91%2.01
4,728.57%6.76
408.51%1.4808
-33.16%1.25
191.49%2.15
69.37%1.88
-97.56%0.14
-140.34%-0.48
46.09%1.87
-250.64%-2.35
Diluted earnings per share
7.49%2.01
4,714.29%6.74
408.33%1.48
-33.33%1.24
191.06%2.14
68.47%1.87
-97.55%0.14
-140.68%-0.48
45.31%1.86
-251.61%-2.35
Dividend per share
5.19%0.81
5.41%3.12
5.19%0.81
5.48%0.77
5.48%0.77
5.48%0.77
5.71%2.96
5.48%0.77
5.80%0.73
5.80%0.73
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue -1.56%15.53B6.74%64.17B6.79%15.62B4.35%16.66B7.16%16.11B8.89%15.78B1.40%60.12B5.78%14.63B6.70%15.96B3.03%15.04B
Operating revenue -1.56%15.53B6.74%64.17B6.79%15.62B4.35%16.66B7.16%16.11B8.89%15.78B1.40%60.12B5.78%14.63B6.70%15.96B3.03%15.04B
Cost of revenue -3.42%3.42B-5.79%15.19B-2.15%3.83B-4.32%4.08B-6.93%3.75B-9.83%3.54B-7.38%16.13B0.80%3.91B8.39%4.26B-4.55%4.02B
Gross profit -1.02%12.11B11.33%48.98B10.06%11.8B7.51%12.58B12.31%12.37B15.85%12.24B5.06%43.99B7.73%10.72B6.10%11.7B6.11%11.01B
Operating expense -4.66%6.17B-29.93%28.75B-40.09%7.45B47.49%8.59B-61.06%6.24B-4.15%6.48B73.95%41.04B92.37%12.43B-15.80%5.83B201.75%16.02B
Selling and administrative expenses 2.78%2.55B2.97%10.82B2.14%2.86B8.42%2.73B1.37%2.74B0.16%2.48B4.60%10.5B4.35%2.8B-0.04%2.52B7.56%2.7B
Research and development costs -9.29%3.62B-41.25%17.94B-52.38%4.58B77.26%5.86B-73.73%3.5B-6.64%3.99B125.35%30.53B155.02%9.63B-24.82%3.31B376.09%13.32B
Operating profit 3.07%5.94B584.53%20.22B353.82%4.35B-32.15%3.98B222.27%6.13B51.34%5.76B-83.84%2.95B-149.13%-1.71B43.01%5.87B-198.91%-5.01B
Net non-operating interest income expense 11.30%-204M-9.60%-856M24.17%-182M16.80%-203M-43.45%-241M-76.92%-230M2.98%-781M-71.43%-240M-19.61%-244M25.33%-168M
Non-operating interest income 49.32%109M13.70%415M108.57%146M73.97%127M-36.70%69M-34.82%73M132.48%365M-26.32%70M82.50%73M626.67%109M
Non-operating interest expense 3.30%313M10.91%1.27B5.81%328M4.10%330M11.91%310M25.21%303M19.13%1.15B31.91%310M29.92%317M15.42%277M
Other net income (expense) 21.43%170M301.06%571M104.30%4M3,962.50%309M176.77%119M638.46%140M72.51%-284M-156.02%-93M97.49%-8M56.34%-155M
Gain on sale of security -----610.00%-213M-230.65%-205M45.76%-64M98.31%-4M-84.58%60M98.19%-30M17.33%-62M74.73%-118M35.95%-237M
Special income (charges) 43.90%-69M48.41%-309M80.00%-51M55.56%-56M47.02%-80M-83.58%-123M-77.74%-599M-420.41%-255M-34.04%-126M-6.34%-151M
-Less：Restructuring and merger&acquisition -43.90%69M-48.41%309M-80.00%51M-55.56%56M-47.02%80M83.58%123M77.74%599M420.41%255M34.04%126M6.34%151M
Other non- operating income (expenses) 17.73%239M216.81%1.09B16.07%260M81.78%429M-12.88%203M158.33%203M-64.06%345M-22.76%224M-2.48%236M48.41%233M
Income before tax 4.11%5.9B955.37%19.94B303.81%4.17B-27.22%4.09B212.58%6.01B55.34%5.67B-88.51%1.89B-158.24%-2.05B56.85%5.62B-218.90%-5.34B
Income tax -9.41%818M85.38%2.8B151.95%426M6.78%929M-14.44%545M9.45%903M-21.17%1.51B-265.66%-820M163.64%870M18.40%637M
Net income 6.67%5.09B4,444.56%17.13B405.38%3.74B-33.45%3.16B191.44%5.46B68.74%4.77B-97.40%377M-140.62%-1.23B46.02%4.75B-251.23%-5.97B
Net income continuous Operations 6.67%5.09B4,444.56%17.13B405.38%3.74B-33.45%3.16B191.44%5.46B68.74%4.77B-97.40%377M-140.62%-1.23B46.02%4.75B-251.23%-5.97B
Minority interest income 20.00%6M33.33%16M1M-20.00%4M100.00%6M25.00%5M71.43%12M00.00%5M-40.00%3M
Net income attributable to the parent company 6.66%5.08B4,589.59%17.12B405.30%3.74B-33.47%3.16B191.30%5.46B68.81%4.76B-97.49%365M-140.64%-1.23B46.09%4.75B-251.50%-5.98B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 6.66%5.08B4,589.59%17.12B405.30%3.74B-33.47%3.16B191.30%5.46B68.81%4.76B-97.49%365M-140.64%-1.23B46.09%4.75B-251.50%-5.98B
Basic earnings per share 6.91%2.014,728.57%6.76408.51%1.4808-33.16%1.25191.49%2.1569.37%1.88-97.56%0.14-140.34%-0.4846.09%1.87-250.64%-2.35
Diluted earnings per share 7.49%2.014,714.29%6.74408.33%1.48-33.33%1.24191.06%2.1468.47%1.87-97.55%0.14-140.68%-0.4845.31%1.86-251.61%-2.35
Dividend per share 5.19%0.815.41%3.125.19%0.815.48%0.775.48%0.775.48%0.775.71%2.965.48%0.775.80%0.735.80%0.73
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
BAWEI
837023
+29.97%
XI'AN WONDER
836419
+28.12%
Jiangsu Tiangong Technology
920068
+20.29%
4
Fujian Green Pine
300132
+20.08%
5
Yili Chuanning Biotechnology
301301
+20.03%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Earnings Season Underway

Earnings season is here. What to know?